Cell-surface expression of lymphocyte activation markers in myasthenia gravis

Autoimmunity

Volumn 31, Issue 1, 1999, Pages 55-66

  Ragheb, Samia ^a,b   Bealmear, Beverly ^a,b   Lisak, Robert ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DETROIT MEDICAL CENTER   (United States)

Author keywords

B cells; Lymphocyte activation; Myasthenia gravis; T cells; Transferrin receptor; T cell receptor; T cell receptor

Indexed keywords

CD14 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD40 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; CHOLINERGIC RECEPTOR; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 2 RECEPTOR; PYRIDOSTIGMINE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL HETEROGENEITY; CELL ISOLATION; CELL SURFACE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; MYASTHENIA GRAVIS; ONSET AGE; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0033278099     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908993860     Document Type: Article

References (58)

1. J. Patrick and J. Lindstrom. Autoimmune response to acetylcholine receptors. Science 1973; 180: 871-872.
2. S. Ragheb and R.P. Lisak. The immunopathogenesis of acquired (auto-immune) myasthenia gravis. In: Lisak, R.P. Ed. Handbook of Myasthenia Gravis and Myasthenic Syndromes. Dekker. 1994; pp. 239-276.
3. A.G. Engel, E.H. Lambert and F.M. Howard. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiological correlations. Mayo Clin. Proc. 1977; 52: 267-280.
4. D.B. Drachman, R.N. Adams, L.F. Josifek and S.G. Self. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 1982; 307: 769-775.
5. T. Ashikawa and S.H. Appel. Immunopathologic events at the endplate in myasthenia gravis. Springer Sem. Immunopathol. 1985; 8: 177-196.
6. S.H. Appel, R.R. Almon and N.R. Levy. Acetylcholine receptor antibodies in myasthenia gravis. N. Engl. J. Med. 1975; 293: 760-761.
7. J.M. Lindstrom, M.E. Seybold, V.A. Lennon, S. Whittingham and D.D. Duane. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054-1059.
8. P.C. Limburg, T.H. The, W. Hummel-Tappel and H.J.G.H. Oosterhuis. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part I. Relation to clinical parameters in 250 patients. J. Neural. Sci. 1983; 58: 457-470.
9. N. Shinomiya and J. Yata. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis. Clin. Exp. Immunol. 1981; 46: 277-285.
10. H.N.A. Willcox, J. Newsom-Davis and L.R. Calder. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin. Exp. Immunol. 1984; 58: 97-106.
11. P.C. Limburg, E. Hummel-Tappel, H.J. Oosterhuis and T.H. The. In vitro T-cell dependent B-cell activity in myasthenia gravis. Clin. Exp. Immunol. 1985; 61: 31-38.
12. B. Castleman. The pathology of the thymus gland in myasthenia gravis. Ann. N. Y. Acad. Sci. 1966; 135: 496-503.
13. G. Goldstein. Myasthenia gravis and the thymus. Ann. Rev. Med. 1971; 22: 119-124.
14. N.I. Abdou, R.P. Lisak, B. Zweiman, I. Abrahamson and A.S. Penn. The thymus in myasthenia gravis. Evidence for altered cell populations. N. Engl. J. Med. 1974; 291: 1271-1275.
15. A. Aharonov, R. Tarrab-Hazdai, O. Abramsky and S. Fuchs. Immunological relationships between acetylcholine receptor and thymus: a possible significance in myasthenia gravis. Proc. Natl. Acad. Sci. USA 1975; 72: 1456-1459.
16. W.K. Engel, M.L. Trotter, D.E. McFarlin and C.L. McIntosh. Thymic epithelial cell contains acetylcholine receptor. Lancet 1977; 1: 1310-1311.
17. I. Kao and D.B. Drachman. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 1977; 195: 74-75.
18. A. Vincent, G.K. Scadding, H.C. Thomas and J. Newsom-Davis. In vitro synthesis of anti-acetylcholine receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1978; 1: 778-779.
19. M.J. Kornstein, J.J. Brooks, A.O. Anderson, A.I. Levinson, R.P. Lisak and B. Zweiman. The immunohistology of the thymus in myasthenia gravis. Am. J. Pathol. 1984; 117: 184-194.
20. A.I. Levinson, B. Zweiman, R.P. Lisak, A. Dziarski and A.R. Moskovitz. Thymic B-cell activation in myasthenia gravis. Neurology 1984; 34: 462-468.
21. Y. Fujii, Y. Monden, K. Nakahara, J. Hashimoto and Y. Kawashima. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology 1984; 34: 1182-1186.
22. R.P. Lisak, A.I. Levinson, B. Zweiman and M.J. Kornstein. Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes. J. Immunol. 1986; 137: 1221-1225.
23. M. Schluep, N. Willcox, M.A. Ritter, J. Newsom-Davis, M. Larché and A.N. Brown. Myasthenia gravis thymus: clinical, histological and culture correlations. J. Autoimmunity 1988; 1: 445-467.
24. A. Melms, B.C.G. Schalke, T. Kirchner, H.K. Muller-Hermelink, E. Albert and H. Wekerle. The thymus in myasthenia gravis: isolation of T lymphocyte lines specific for the nicotinic acetylcholine receptor from the thymuses of myasthenic patients. J. Clin. Invest. 1988; 81: 902-907.
25. N. Sommer, N. Willcox, G.C. Harcourt and J. Newsom-Davis. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann. Neurol. 1990; 28: 312-319.
26. S. Nelson and B.M. Conti-Tronconi. Adult thymus expresses an embryonic nicotinic acetylcholine receptor-like protein. J. Neuroimmunol. 1990; 29: 81-92.
27. L.M. Wheatley, D. Urso, K. Tumas, J. Maltzman, E. Loh and A.I. Levinson. Molecular evidence for the expression of nicotinic acetylcholine receptor α-chain in mouse thymus. J. Immunol. 1992; 148: 3105-3109.
28. S. Cohen-Kaminsky, C. Gaud, E. Morel and S. Berrih-Aknin. High recombinant IL-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters. J. Autoimmunity 1989; 2: 241-258.
29. S. Cohen-Kaminsky, P. Levasseur, J.P. Binet and S. Berrih-Aknin. Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis. J. Neuroimmunol. 1989; 24: 75-85.
30. R.P. Lisak, B. Zweiman and S.M. Phillips. Thymic and peripheral blood T-and B-cell levels in myasthenia gravis. Neurology 1978; 28: 1298-1301.
31. P. Aisen. Transferrin, the transferrin receptor, and the uptake of iron by cells. Met. Ions Biol. Syst. 1998; 35: 585-631.
32. G.F. Burns, T. Triglia, J.A. Werkmeister, C.G. Begley and A.W. Boyd. TLiSAl, a human T lineage-specific activation antigen involved in the differentiation of cytoloxic T lymphocytes and anomalous killer cells from their precursors. J. Exp. Med. 1985; 161: 1063-1078.
33. N. Fujii, Y. Itoyama, T. Tabira and Y. Kuroiwa. Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis. J. Neuroimmunol. 1983; 4: 151-159.
34. S. Berrih, C. Gaud, M. Bach, H. Le Brigand, J. Binet and J. Bach. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin. Exp. Immunol. 1981; 45: 1-8.
35. P.R. Skolnik, R.P. Lisak and B. Zweiman. Monoclonal antibody analysis of blood T cell subsets in myasthenia gravis. Ann. Neurol. 1982; 11: 170-176.
36. P. Emery, K.C. Gentry, I.R. Mackay, K.D. Muirden and M. Rowley. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum. 1987; 30: 849-856.
37. H. Shimizu, Y. Ichikawa, M. Yoshida, K. Takahashi and S. Arimori. Lymphocyte subsets of the peripheral blood in myasthenia gravis determined by two-color flow cytometry. Autoimmunity 1990; 6: 173-182.
38. L.M. Neckers. Regulation of transferrin receptor expression and control of cell growth. Pathobiology 1991; 59: 11-18.
39. P.A. Seligman, J. Kovar and E.W. Gelfand. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiology 1992; 60: 19-26.
40. A.I. Levinson, A. Dziarski, R.P. Lisak, B. Zweiman, T. Brenner and O. Abramsky. Polyclonal B-cell activity in myasthenia gravis. Neurology 1981; 31: 1198-1201.
41. R.P. Lisak, C. Laramore, B. Zweiman and A. Moskovitz. In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood mononuclear cells of patients with myasthenia gravis. Neurology 1983; 33: 604-608.
42. S. Ragheb and R.P. Lisak. Phenotypic and functional abnormalities of B-cells in myasthenia gravis. Ann. N. Y. Acad. Sci. 1993; 681: 256-263.
43. A. von Bonin, J. Hühn and B. Fleischer. Dipeplidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunological Rev. 1998: 161: 43-53.
44. C. Morimoto and S.F. Schlossman. The structure and function of CD26 in the T-cell immune response. Immunological Rev. 1998; 161: 55-70.
45. N.E. Street and T.R. Mosmann. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991; 5: 171-177.
46. Y.H. Chien, R. Jores and M.P. Crowley. Recognition by gamma/delta T cells. Ann. Rev. Immunol. 1996; 14: 511-532.
47. S.H.E. Kaufmann. γδ and other unconventional T lymphocytes: what do they see, and what do they do? Proc. Natl. Acad. Sci. USA 1996; 93: 2272-2279.
48. A. Hayday and L. Geng. γδ cells regulate autoimmunity. Curr. Opinion in Immunol. 1997; 9: 884-889.
49. R. Troncone, L. Greco, M. Mayer, F. Paparo, N. Caputo, M. Micillo et al. Latent and potential coeliac disease. Acta Paediat. 1996; 412: 10-14.
50. + oligodendrocytes in multiple sclerosis. Proc. Natl. Acad Sci. USA 1991, 88: 6452-6456.
51. J. Hvas, J. R. Oksenberg, R. Fernando, L. Steinman and C.C.A. Bernard. γδ T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmunol. 1993; 46: 225-234.
52. R. Shimonkevitz, C. Colburn, J.A. Burham, R.S. Murray and B.L. Kotzin. Clonal expansions of activated γ/δ T cells in recent-onset multiple sclerosis. Proc. Natl. Acad. Sci. USA 1993; 90: 923-927.
53. P. Stinissen, C. Vandevyver, R. Medaer, L. Vandegaer, J. Nies, L. Tuyls et al. Increased frequency of γδ T-cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. J. Immunol. 1995; 154: 4883-4894.
54. C. Olive. γδ T-cell receptor variable region usage during the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 1995; 62: 1-7.
55. A.J. Rajan, Y.L. Gao, C.S. Raine and C.F. Brosnan. A pathogenic role of γδ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 1996; 157: 941-949.
56. L.C. Harrison, M. Dempsey-Collier, D.R. Kramer and K. Takahashi. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 1996; 184: 2167-2174.
57. + cells suppress experimental autoimmune uveitis. Eur. J. Immunol. 1996; 26: 2140-2148.
58. Y. Kobayashi, K. Kawai, K. Ito, H. Honda, G. Soube and Y. Yoshikai. Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor γδ specific antibody. J. Neuroimmunol. 1997; 73: 169-174.